OTC · Biotechnology

LakeShore Biopharma Co., Ltd (LSBCF) Stock

$0.07 +0.00% OTC: LSBCF Healthcare

LakeShore Biopharma Co., Ltd (LSBCF) is a biopharmaceutical firm dedicated to the end-to-end process of bringing innovative medical solutions to market. Its primary focus lies in creating vaccines and advanced therapeutic biologics, specifically designed to combat infectious diseases and various forms of cancer.

Valuation

MetricValue
Price$0.07
Market Cap$2.76M
P/E Ratio-0.48
P/B Ratio0.10
P/S Ratio0.03
EPS (TTM)$-0.94
52-Week High$1.48
52-Week Low$0.03
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-18.43%
ROA-7.31%
ROCE-15.89%
Gross Margin82.47%
Operating Margin-14.03%
Net Margin-16.26%
Debt/Equity0.83
Current Ratio1.02

Annual Financials (USD)

Metric20212022202320242025
Revenue$257.0M$503.0M$687.0M$573.0M$615.0M
Operating Profit$-126.0M$-119.0M$-139.0M$-446.0M$-86.0M
Net Profit$-192.0M$-237.0M$-145.0M$-433.0M$-100.0M
EPS$-6.67$-0.02$-1.88$-4.05$-0.94
Op Margin-49.0%-23.6%-20.3%-77.8%-14.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$201.0M$1.7B$1.5B$1.4B
Total Liabilities$0$20.0M$991.0M$928.0M$868.0M
Cash$390.0M$271.0M$370.0M$246.0M$28.0M
Borrowings$19.0M$381.0M$499.0M$424.0M$414.0M

Latest News

Horizon Bancorp Q2 Earnings, Revenue Rise MT Newswires · Jul 22, 2026 4 Leadership Habits That Build Sustainable Operational Standards FSR · Jul 22, 2026 Century Communities Q2 Adjusted Earnings, Revenue Fall MT Newswires · Jul 22, 2026 Filing of Leven Star Reef Technical Report GlobeNewswire · Jul 22, 2026 Home BancShares, Inc. Announces Increase in Quarterly Dividend GlobeNewswire · Jul 22, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-247.0M$-1.0M$-182.0M$-295.0M$-121.0M
Investing Cash Flow$-209.0M$-598.0M$-114.0M$-89.0M$-35.0M
Financing Cash Flow$0$0$217.0M$0$0
Net Cash Flow$388.0M$-119.0M$99.0M$-124.0M$-139.0M
Free Cash Flow$-351.0M$-300.0M$-240.0M$-339.0M$-139.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA-8.34
FCF Yield-743.60%
Quick Ratio0.75
Interest Coverage-5.48
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held88.42%
Institutions Held1.47%
Institutions Float Held12.71%
Institutional HolderSharesReport Date
Barclays Plc24,7572025-09-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACOGFAlpha Cognition Inc. $5.73 — -38.17 $35.66M 0.00%
DMTTFSmall Pharma Inc. $0.11 -9.69% -2.20 $37.51M 0.00%
EMMLFOKYO Pharma Limited $0.01 +0.00% -6.48 $22.73M 0.00%
IBXNFIBEX Technologies Inc. $1.00 -6.54% 9.06 $25.27M 0.00%
IGXTIntelGenx Technologies Corp. $0.17 +0.00% -2.99 $29.69M 0.00%

About LakeShore Biopharma Co., Ltd

LakeShore Biopharma Co., Ltd (LSBCF) is a biopharmaceutical firm dedicated to the end-to-end process of bringing innovative medical solutions to market. Its primary focus lies in creating vaccines and advanced therapeutic biologics, specifically designed to combat infectious diseases and various forms of cancer. A cornerstone of its strategy is the proprietary PIKA immunomodulating technology platform. This innovative platform underpins the development of several key pipeline assets, including a PIKA rabies vaccine, a PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. LakeShore Biopharma maintains operations across an international footprint, with a presence in China, the United States, Singapore, the United Arab Emirates, and the Philippines. Established in 2002, the company was initially known as YS Biopharma Co., Ltd. It rebranded to LakeShore Biopharma Co., Ltd in May 2024. The company's corporate headquarters are located in Beijing, China.

LakeShore Biopharma Co., Ltd is headquartered in CN.

LakeShore Biopharma Co., Ltd (LSBCF) stock trades at $0.07 with a market capitalization of $2.76M. The stock is valued at a price-to-earnings (P/E) ratio of -0.48, price-to-book of 0.10, price-to-sales of 0.03. Over the past 52 weeks the stock has ranged between $0.03 and $1.48, and currently trades 95.3% below its 52-week high.

On profitability, LakeShore Biopharma Co., Ltd generates a return on equity (ROE) of -18.43%, return on capital employed of -15.89%, an operating margin of -14.03%, a net profit margin of -16.26%.

Official website: www.lakeshorebio.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides